Bourgeon Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-5,627
| Closed | -$13K | – | 289 |
|
2023
Q4 | $13K | Hold |
5,627
| – | – | ﹤0.01% | 233 |
|
2023
Q3 | $14.7K | Hold |
5,627
| – | – | ﹤0.01% | 217 |
|
2023
Q2 | $20.1K | Hold |
5,627
| – | – | ﹤0.01% | 211 |
|
2023
Q1 | $12.3K | Hold |
5,627
| – | – | ﹤0.01% | 224 |
|
2022
Q4 | $67.7K | Hold |
5,627
| – | – | 0.02% | 138 |
|
2022
Q3 | $36K | Hold |
5,627
| – | – | 0.01% | 148 |
|
2022
Q2 | $26K | Hold |
5,627
| – | – | 0.01% | 167 |
|
2022
Q1 | $49K | Hold |
5,627
| – | – | 0.01% | 143 |
|
2021
Q4 | $80K | Hold |
5,627
| – | – | 0.02% | 133 |
|
2021
Q3 | $124K | Hold |
5,627
| – | – | 0.03% | 120 |
|
2021
Q2 | $75K | Hold |
5,627
| – | – | 0.02% | 146 |
|
2021
Q1 | $57K | Hold |
5,627
| – | – | 0.01% | 156 |
|
2020
Q4 | $24K | Hold |
5,627
| – | – | 0.01% | 171 |
|
2020
Q3 | $15K | Hold |
5,627
| – | – | ﹤0.01% | 196 |
|
2020
Q2 | $20K | Hold |
5,627
| – | – | 0.01% | 163 |
|
2020
Q1 | $17K | Hold |
5,627
| – | – | 0.01% | 157 |
|
2019
Q4 | $29K | Hold |
5,627
| – | – | 0.01% | 136 |
|
2019
Q3 | $18K | Buy |
+5,627
| New | +$18K | 0.01% | 154 |
|